Vimarsana
Biggest News Aggregation in the World

Page 3 - Mandy Fahey News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mandy Fahey. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mandy Fahey Today - Breaking & Trending Today

Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference - Vimarsana News

Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference

—ARIKAYCE® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net...

Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference - Vimarsana News

Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference

BRIDGEWATER, N.J., Jan. 2, 2024 /PRNewswire/ -- Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today...

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Vimarsana News

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

BRIDGEWATER, N.J., Nov. 3, 2023 /PRNewswire/ -- Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today...

Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update - Vimarsana News

Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update

—ARIKAYCE® Total Revenue of $79.1 Million for the Third Quarter of 2023 Reflects Highest Quarter of Sales Since Launch and 17% Growth Compared to the Third Quarter of 2022— —Company...

Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List - Vimarsana News

Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...